过灌的功能影响:从神经性肠道功能障碍的病理生理学和临床研究的见解
Gianna Rodriguez1, Steven Kirshblum2, Mai Thao3
1Physical Medicine and Rehabilitation, Spinal Cord Injury Medicine, University of Michigan Health, Ann Arbor, MI 48108, USA.
Journal of clinical medicine
|March 28, 2024
概括
过门灌 (TAI) 通过改善便疏散,有助于神经性肠道功能障碍 (NBD). 了解 TAI 的理解
科学领域:
- 胃肠病学 胃肠病学
- 神经学 神经学
- 康复医学 康复医学 康复医学
背景情况:
- 神经性肠道功能障碍 (NBD) 显著损害排便,影响生活质量.
- NBD涉及便失禁和/或便秘,需要有效的肠道管理.
- 过门灌 (TAI) 是推的二线治疗NBD.
研究的目的:
- 审查目前对 TAI 作用机制的理解.
- 探索TAI在神经性肠道和不规则排便中的功能影响.
- 引导TAI在NBD肠道护理计划中的临床整合.
主要方法:
- 在神经性肠道功能障碍中对TAI机制的文献综述.
- 分析延迟结肠运动和便排泄障碍的病理生理学.
- 检查TAI在对保守治疗无反应的患者中的作用.
主要成果:
- 作为二线NBD治疗,TAI提供了既定的安全性和有效性.
- TAI的精确机制,特别是气球导管,需要进一步阐明.
- TAI可以解决由于延迟运动和自愿控制受损而导致的便秘.
结论:
- 了解TAI的机制可以优化其在NBD管理中的使用.
- 对于耐火性NBD便秘的患者来说,TAI是一个有价值的选择.
- 对TAI的功能影响进行进一步的研究是有必要的,以改善临床实践.
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
272
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
272
01:21Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145
01:17Drugs for Treatment of Diarrhea-Predominant IBS
166
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
166
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
159
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
159
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
201
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
201
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
210
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
210